These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7946458)

  • 1. Effective cytotoxic treatment of primary plasma cell leukaemia--a report of 3 cases.
    Gangadharan VP; Satishkumar K; Pillai R; Cherian V
    Acta Oncol; 1994; 33(6):714-5. PubMed ID: 7946458
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma cell leukemia--report on two cases.
    Singh VP; Sundar S; Kumar K; Shukla J; Dube B
    J Assoc Physicians India; 1994 Oct; 42(10):824-5. PubMed ID: 7876056
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy].
    Shindo T; Yumoto Y; Yoshida M; Okuda T
    Rinsho Ketsueki; 2002 Feb; 43(2):107-11. PubMed ID: 11925872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete remission in plasma cell leukaemia.
    Krsnik I; Peñalver MA; Del Potro E; Diaz-Mediavilla J
    Br J Haematol; 1987 May; 66(1):145. PubMed ID: 3593651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
    Sureda A; Pérez de Oteyza J; García Laraña J; Odriozola J
    Sangre (Barc); 1989 Jun; 34(3):244. PubMed ID: 2762986
    [No Abstract]   [Full Text] [Related]  

  • 6. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
    Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
    Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma cell leukemia: our experience in 4 cases].
    Manso F; Bello JL; Feliu J; García de Bustos J; Losada G; Quevedo E
    Rev Clin Esp; 1991 Nov; 189(7):328-30. PubMed ID: 1767090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen.
    Libby E; Candelaria-Quintana D; Moualla H; Abdul-Jaleel M; Rabinowitz I
    Am J Hematol; 2010 Sep; 85(9):733-4. PubMed ID: 20669178
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of the successful treatment of acute plasmablastic leukemia].
    Rekhtina IG; Shchekochikhin SM
    Ter Arkh; 1997; 69(11):70-1. PubMed ID: 9483754
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
    Kumagai K; Takagi T; Sakai C; Wakatsuki S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
    Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature.
    Hovenga S; de Wolf JT; Klip H; Vellenga E
    Bone Marrow Transplant; 1997 Nov; 20(10):901-4. PubMed ID: 9404934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha.
    Yamagata N; Shimazaki C; Goto H; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Nakagawa M
    Am J Hematol; 1994 Mar; 45(3):262-4. PubMed ID: 8296801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma cell leukemia].
    Morey M; Bargay J; Galmes A; Besalduch J
    Sangre (Barc); 1989 Jun; 34(3):245. PubMed ID: 2762987
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
    Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
    Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term disease-free survival in a primary plasma cell leukemia treated by VAD, autologous PBSC transplantation, and IFN-alpha.
    Büchler T; Ferra C; Domingo A; Gallardo D; Sarra J; Grańena A
    Am J Hematol; 2002 Sep; 71(1):62. PubMed ID: 12221683
    [No Abstract]   [Full Text] [Related]  

  • 17. [Four cases of therapy-related leukemia in multiple myeloma].
    Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of intensive induction and consolidation therapy in acute lymphoblastic leukaemia in children.
    Sanchetee SC; Pai SK; Pai VR; Kurkure PA; Shetty PA
    Indian J Cancer; 1985 Sep; 22(3):217-20. PubMed ID: 3870462
    [No Abstract]   [Full Text] [Related]  

  • 19. VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia.
    Ataergin S; Arpaci F; Kaya A; Cetin T; Gunhan O
    Am J Hematol; 2006 Dec; 81(12):987-8. PubMed ID: 16888783
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.
    Sajeva MR; Greco MM; Cascavilla N; D'Arena G; Scalzulli P; Melillo L; Minervini MM; Bonini A; Di Mauro L; Carotenuto M; Musto P
    Bone Marrow Transplant; 1996 Jul; 18(1):225-7. PubMed ID: 8832022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.